Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model. - Wikidata - awgldk - TriplyDB

Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model.

Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model.

http://www.wikidata.org/entity/Q34929504

about

Rhabdomyosarcoma of the head and neck in children Molecular profiling of childhood cancer: Biomarkers and novel therapies Inflammatory stress and sarcomagenesis: a vicious interplay.Identifying novel therapeutic agents using xenograft models of pediatric cancer.In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cells.NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition.

P2860

Q35648994-C575F99E-0764-461D-85BB-7B5533C657FA Q36250783-2532E7DB-B7F8-4DE9-8512-0E3F58BE703C Q37378867-59848EA4-AA02-4C01-A235-C4CB0B8AD0EA Q38837564-98F3D026-3454-4207-9068-A9DD8934E205 Q38936986-5849A117-9146-478C-9A7D-1898B5B5BC09 Q41815541-979A284E-6EDA-4D3C-B585-1DFEA598E5EE

P2860

Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model.

http://www.wikidata.org/entity/Q34929504

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model.

@ast

Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model.

@en

Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model.

@nl

type

label

Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model.

@ast

Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model.

@en

Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model.

@nl

prefLabel

Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model.

@ast

Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model.

@en

Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model.

@nl

P1433

Q34929504-B0C03D5F-1BF4-4222-9500-EB30936BE425

P1476

Q34929504-C52FC69F-F8DB-432B-91A4-D377FC8098C4

P2093

Q34929504-013695C9-9F13-4D08-BBF9-945E4002756E

Q34929504-02B166F0-CBCF-4B0A-B298-13E7C19D6589

Q34929504-180A2473-ABBA-4404-B7DA-5701431255A4

Q34929504-21B1E7BD-0FC2-46F1-A66A-AF6E896622F9

Q34929504-525CC53F-E188-40F9-963B-D867CCEF3CC4

Q34929504-69CA675E-EDA7-4F8D-9DA6-82DF6054DDB1

Q34929504-8D74CE85-D494-4EC4-8A4E-045C606367DC

Q34929504-AD35F27B-372B-4D64-A192-C28FFF10F7C3

Q34929504-FF09B38D-9400-4BA1-AB56-F041B35C6786

P2860

Q34929504-09A3E647-E2D6-484A-9AA7-2B9EFC91F2B2

Q34929504-136FD93F-F143-4AC8-B781-AE7775B6BB95

Q34929504-1EAF9C1A-520E-416D-9677-23B25FBC2A92

Q34929504-3CB55C61-B53A-4553-97AD-BE4AF3BC1B3B

Q34929504-5182121C-C90B-444F-97A7-2930BDBDD2E3

Q34929504-5ED16E23-3977-4E63-83D9-E471F582CDD0

Q34929504-A24069B9-F9B3-4E18-9F78-84BCBE9FFD93

Q34929504-A550654B-DB0C-48B0-9E20-91F530CB9B41

Q34929504-AEA308F8-56D7-4263-A233-534278F0E4D8

Q34929504-D942FBC1-E077-44A1-ACB2-1C565B00C2BB

P304

Q34929504-600E02E0-FC61-4709-B01B-7FBB7DC304FE

P31

Q34929504-A1FDCC6D-D93A-42B2-8E13-B082487E68CD

P356

Q34929504-9586AD47-181E-49E7-A0D1-A20EAC6D3969

P478

Q34929504-2C49BFE9-B2EB-44EB-82D7-66B7FD71A967

P50

Q34929504-A5A19792-5DE0-4D89-BCB9-9D14A7121CA6

P577

Q34929504-B5C5516C-9799-40D3-BB0F-BF406411B144

P5875

Q34929504-3C1C9F3A-6877-4BF6-92A0-00C2AC361CA1

P698

Q34929504-0F183C47-27D7-4D69-8329-02C5CD4FD033

P932

Q34929504-6D7955A0-5514-43D5-B8CF-885F4DED9C9D

P356

P1433

P1476

Preclinical testing of erlotinib in a transgenic alveolar rhabdomyosarcoma mouse model

@en

P2093

Aoife Kilcoyne

http://www.w3.org/2001/XMLSchema#string

Brian P Rubin

http://www.w3.org/2001/XMLSchema#string

Courtney B Kubicek

http://www.w3.org/2001/XMLSchema#string

Francis J Giles

http://www.w3.org/2001/XMLSchema#string

Jinu Abraham

http://www.w3.org/2001/XMLSchema#string

Joel E Michalek

http://www.w3.org/2001/XMLSchema#string

Laura D Nelon

http://www.w3.org/2001/XMLSchema#string

Lee Ann Zarzabal

http://www.w3.org/2001/XMLSchema#string

Sheila T Hampton

http://www.w3.org/2001/XMLSchema#string

P2860

Erlotinib in previously treated non-small-cell lung cancer

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib.

Common musculoskeletal tumors of childhood and adolescence.

EGFR signaling and drug discovery.

Metastatic rhabdomyosarcoma: a retrospective review of patients treated at the hospital for sick children between 1989 and 1999.

Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study

Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma.

Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.

Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.

P304

130484

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/130484

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51114281

http://www.w3.org/2001/XMLSchema#string

P698

21559212

http://www.w3.org/2001/XMLSchema#string

P932

3087964

http://www.w3.org/2001/XMLSchema#string